Ciprofloxacin in combination with other antimicrobials

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Ciprofloxacin is a widely used fluoroquinolone antibiotic.
• Understanding antibiotic combinations is crucial for effective treatment strategies.
• Interactions between antibiotics can lead to synergy, antagonism, or indifference.

Purpose of the Study:

• To evaluate the synergistic and antagonistic effects of ciprofloxacin combined with aminoglycosides or beta-lactams.
• To assess these interactions against key bacterial pathogens, including Enterobacteriaceae, Gram-positive bacteria, and Pseudomonas aeruginosa.

Main Methods:

• The study likely involved in vitro susceptibility testing of bacterial isolates.
• Combinations of ciprofloxacin with specific aminoglycosides and beta-lactams were tested.
• Microbiological assays were used to determine synergistic, antagonistic, or indifferent effects.

Main Results:

• Combinations of ciprofloxacin with aminoglycosides or beta-lactams showed infrequent synergy and rare antagonism against Enterobacteriaceae and Gram-positive bacteria.
• Against Pseudomonas aeruginosa, synergy between ciprofloxacin and aminoglycosides was observed in a minority of isolates.
• The synergistic interactions between ciprofloxacin and beta-lactams against Pseudomonas aeruginosa exhibited considerable variability.

Conclusions:

• Antibiotic combinations involving ciprofloxacin have limited synergistic potential against many common bacterial pathogens.
• The efficacy of ciprofloxacin combinations, particularly against Pseudomonas aeruginosa, is isolate-dependent and varies significantly.
• These findings highlight the complexity of antibiotic interactions and the need for careful consideration in clinical practice.